Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Type 2 diabetes and hypoglycemia

Journal articles and book chapters

09-10-2018 | Insulin glargine | Article

Association of patient profile with glycemic control and hypoglycemia with insulin glargine 300 U/mL in type 2 diabetes: A post hoc patient-level meta-analysis

Twigg SM et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0498-x

08-29-2018 | Hypoglycemia | Article

A post hoc pooled analysis to evaluate hypoglycemia risk with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in people with type 2 diabetes on a basal‐only insulin regimen

Bolli GB et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13515

08-22-2018 | Hypoglycemia | Article

Male patients with longstanding type 2 diabetes have a higher incidence of hypoglycemia compared with female patients

Li F et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0492-3

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

07-03-2018 | Hypoglycemia | Article

Association of initiation of basal insulin analogs vs neutral protamine Hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes

Lipska KJ et al. JAMA 2018; 320: 53–62. doi: 10.1001/jama.2018.7993

06-30-2018 | Insulin NPH | Article

Glycemic control in hospitalized patients with diabetes receiving corticosteroids using a neutral protamine Hagedorn insulin protocol: A randomized clinical trial

Khowaja A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0468-3

06-27-2018 | Metformin | Article

Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan

Matsuura N et al. Diabetol Int 2018. doi: 10.1007/s13340-018-0361-3

06-23-2018 | Devices and technology | Review | Article

Diabetes technology update: Use of insulin pumps and continuous glucose monitoring in the hospital

Umpierrez GE, Klonoff DC. Diabetes Care 2018. doi: 10.2337/dci18-0002

06-22-2018 | Gastroparesis | Review | Article

Diabetic gastroparesis: Principles and current trends in management

Krishnasamy S, Abell TL. Diabetes Ther (2018); 9 (Suppl 1): 1. doi: 10.1007/s13300-018-0454-9

06-21-2018 | Hypoglycemia | Review | Article

Hypoglycemia among patients with type 2 diabetes: Epidemiology, risk factors, and prevention strategies

Silbert R et al. Curr Diab Rep 2018; 18: 53. doi: 10.1007/s11892-018-1018-0

06-20-2018 | Ipragliflozin | Article

Ipragliflozin add-on therapy to a GLP-1 receptor agonist in Japanese patients with type 2 diabetes (AGATE): A 52-week open-label study

Ishihara H et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0455-8

06-16-2018 | Medications | Review | Article

Availability and affordability of essential medicines: Implications for global diabetes treatment

Beran D et al. Curr Diab Rep 2018; 18: 48. doi: 10.1007/s11892-018-1019-z

06-16-2018 | Risk factors | Review | Article

Methods for measuring risk for type 2 diabetes in youth: The oral glucose tolerance test (OGTT)

Chen ME, Aguirre RS, Hannon TS. Curr Diab Rep 2018; 18: 51. doi: 10.1007/s11892-018-1023-3

06-14-2018 | Hypoglycemia | Article

Hypoglycemia, cardiovascular outcomes, and death: The LEADER experience

Zinman B et al. Diabetes Care 2018: dc172677. doi: 10.2337/dc17-2677

06-12-2018 | Blood glucose monitoring | Article

Long-term effect of the color record method in self-monitoring of blood glucose on metabolic parameters in type 2 diabetes: A 2-year follow-up of the Color IMPACT study

Nishimura A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0457-6

06-12-2018 | Insulin | Article

A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study

Ritzel R et al. Diabetes Care 2018: dc180168. doi: 10.2337/dc18-0168

06-09-2018 | Cardiovascular disorders | Review | Article

Molecular mechanisms underlying the cardiovascular benefits of SGLT2i and GLP-1RA

Khat DZ, Husain M. Curr Diab Rep 2018; 18: 45. doi: 10.1007/s11892-018-1011-7

06-06-2018 | Mental health | Article

The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes

Saetung S et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1166-3

06-05-2018 | Cardiovascular outcomes | Review | Article

Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: A comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials

Zhuang X et al. Cardiovasc Diabetol 2018; 17: 79. doi: 10.1186/s12933-018-0722-z

Next